A detailed history of Hhm Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hhm Wealth Advisors, LLC holds 5,969 shares of ABBV stock, worth $1.07 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,969
Previous 5,974 0.08%
Holding current value
$1.07 Million
Previous $1.02 Million 15.04%
% of portfolio
0.17%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $819 - $996
-5 Reduced 0.08%
5,969 $1.18 Million
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $265,774 - $310,364
1,717 Added 40.33%
5,974 $1.02 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $50,912 - $57,338
370 Added 9.52%
4,257 $659,000
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $26,718 - $30,930
200 Added 5.42%
3,887 $579,000
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $1,383 - $1,658
-10 Reduced 0.27%
3,687 $0
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $207,220 - $237,667
-1,544 Reduced 29.46%
3,697 $496,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $19,129 - $24,319
-139 Reduced 2.58%
5,241 $803,000
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $198,233 - $245,952
1,502 Added 38.73%
5,380 $872,000
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $6,875 - $8,699
64 Added 1.68%
3,878 $525,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $67,883 - $77,057
638 Added 20.09%
3,814 $411,000
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $35,191 - $38,741
344 Added 12.15%
3,176 $344,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $18,415 - $24,643
-251 Reduced 8.14%
2,832 $278,000
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $38,700 - $58,674
600 Added 24.16%
3,083 $235,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $179,098 - $224,090
2,483 New
2,483 $220,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hhm Wealth Advisors, LLC Portfolio

Follow Hhm Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.